EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis

Estela Area-Gomez, Eric A Schon

Journal of Alzheimer's Disease · 16.04.2024 · 98 (4) · 1243-1275

DOI: 10.3233/jad-231318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 16.04.2024. Verfasst von Estela Area-Gomez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Columbia University, New York, NY, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 427 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The “amyloid cascade” hypothesis of Alzheimer’s disease (AD) pathogenesis invokes the accumulation in the brain of plaques (containing the amyloid-β protein precursor [AβPP] cleavage product amyloid-β [Aβ]) and tangles (containing hyperphosphorylated tau) as drivers of pathogenesis. However, the poor track record of clinical trials based on this hypothesis suggests that the accumulation of these peptides is not the only cause of AD. Here, an alternative hypothesis is proposed in which the AβPP cleavage product C99, not Aβ, is the main culprit, via its role as a regulator of cholesterol metabolism. C99, which is a cholesterol sensor, promotes the formation of mitochondria-associated endoplasmic reticulum (ER) membranes (MAM), a cholesterol-rich lipid raft-like subdomain of the ER that communicates, both physically and biochemically, with mitochondria. We propose that in early-onset AD (EOAD), MAM-localized C99 is elevated above normal levels, resulting in increased transport of cholesterol from the plasma membrane to membranes of intracellular organelles, such as ER/endosomes, thereby upregulating MAM function and driving pathology. By the same token, late-onset AD (LOAD) is triggered by any genetic variant that increases the accumulation of intracellular cholesterol that, in turn, boosts the levels of C99 and again upregulates MAM function. Thus, the functional cause of AD is upregulated MAM function that, in turn, causes the hallmark disease phenotypes, including the plaques and tangles. Accordingly, the MAM hypothesis invokes two key interrelated elements, C99 and cholesterol, that converge at the MAM to drive AD pathogenesis. From this perspective, AD is, at bottom, a lipid disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansMitochondriaEndoplasmic ReticulumAmyloid beta-PeptidesAmyloid beta-Protein PrecursorCholesterol

Stichwörter der Autor:innen

AmyloidC99MAMcholesterolendoplasmic reticulummitochondria

Substanzen

Amyloid beta-PeptidesAmyloid beta-Protein PrecursorCholesterol

Autor:innen und Institutionen

  • Department of Neurology, Columbia University, New York, NY, USA.
  • Centro de Investigaciones Biológicas "Margarita Salas", Spanish National Research Council, Madrid, Spain.
  • Department of Genetics and Development>, Columbia University, New York, NY, USA.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Area-Gomez, E., & Schon, E. A. (2024). Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis. Journal of Alzheimer's Disease, 98(4), 1243-1275. https://doi.org/10.3233/jad-231318

Vancouver

Area-Gomez E, Schon EA. Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis. Journal of Alzheimer's Disease. 2024;98(4):1243-1275. doi:10.3233/jad-231318

BibTeX
@article{AreaGomez2024,
  author = {Area-Gomez, Estela and Schon, Eric A},
  title = {Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis},
  journal = {Journal of Alzheimer's Disease},
  year = {2024},
  volume = {98},
  number = {4},
  pages = {1243--1275},
  doi = {10.3233/jad-231318}
}
Kostenlos starten →